In 2011, Boyer et al. identified that INF2 mutations were a major cause of CMT associated with focal segmental glomerulosclerosis, accounting for 12 of 16 cases in their cohort (Boyer, Nevo, et al., 2011). This evidence concerns the gene INF2 and Charcot-Marie-Tooth disease.